Steve Mahoney

President and Chief Executive Officer @ Viridian Therapeutics arrow icon

About Steve Mahoney

Steve Mahoney is the President and CEO with a diverse background in biopharmaceuticals and law, holding degrees from Boston College and Colorado College.

Known information

Steve Mahoney serves as the President and Chief Executive Officer, bringing a robust educational background with a Master’s in Business Administration from Boston College’s Carroll School of Management and a Juris Doctor from Boston College Law School. He also holds a Bachelor of Arts from Colorado College. Mahoney’s career spans significant roles in the biopharmaceutical industry, including as Chief Financial and Operating Officer of Magenta Therapeutics and President and Chief Operating Officer at Kiniksa Pharmaceuticals, a company he helped found. Earlier, he was the Chief Commercial Officer at Synageva Biopharma and spent about ten years as a commercial attorney at Genzyme Corporation. He began his career as a corporate attorney with Mintz Levin. Additionally, he serves on the board of directors of Vesselon, Inc.

About Viridian Therapeutics

Viridian Therapeutics is a biotechnology company focused on developing innovative medicines for autoimmune and rare diseases, with a strong emphasis on thyroid eye disease.

report flag Report inaccurate information

People similar to Steve Mahoney

Tom Beetham

Chief Operating Officer @ Viridian Therapeutics

Tom Beetham is the Chief Operating Officer at Viridian, with a career spanning over 20 years in various executive roles within the biopharmaceutical industry.

Shan Wu

Chief Business Officer @ Viridian Therapeutics

Shan Wu is the Chief Business Officer with a strong background in biological engineering and business development in the biotechnology sector.

Tony Casciano

Chief Commercial Officer @ Viridian Therapeutics

Tony Casciano is an accomplished pharmaceutical and medical device executive with extensive experience in commercial operations and leadership roles, including his former position as COO & CCO of AMAG Pharmaceuticals and CEO of an MIT medical device spinout.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free